Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano, Disha Bhavsar, Gagandeep Singh, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 106
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
Komal Srivastava, Juan Manuel Carreño, Charles Gleason, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 587-599.e4
Open Access | Times Cited: 34
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 18
Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination
Guy Gorochov, Jacques Ropers, Odile Launay, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e248051-e248051
Open Access | Times Cited: 14
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
Mucosal IgA against SARS-CoV-2 Omicron Infection
Mikael Åberg, Anna Smed‐Sörensen, Charlotte Thålin
New England Journal of Medicine (2022) Vol. 387, Iss. 21
Open Access | Times Cited: 38
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Med (2023) Vol. 4, Iss. 3, pp. 191-215.e9
Open Access | Times Cited: 35
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Elena Mitsi, Mariana O. Diniz, Jesús Reiné, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
Hailey Hornsby, Alexander R. Nicols, Stéphanie Longet, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 10
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity
Sabryna Nantel, Salma Sheikh‐Mohamed, Gary Chao, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 201-210
Open Access | Times Cited: 9
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Oscar Bladh, Katherina Aguilera, Ulrika Marking, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges
Bryce M. Warner, Jacob G. E. Yates, Robert Vendramelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection
Shô Miyamoto, Takara Nishiyama, Akira Ueno, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 52
Open Access | Times Cited: 20
Long-term adaptive response in COVID-19 vaccine recipients and the effect of a booster dose
Luca Perico, Marta Todeschini, Federica Casiraghi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
Stefan Slamanig, Irene González‐Domínguez, Lauren A Chang, et al.
EBioMedicine (2024) Vol. 105, pp. 105185-105185
Open Access | Times Cited: 5
Comprehensive analyses of immune activity in COVID-19-vaccinated idiopathic pulmonary fibrosis patients
Agata Maciejewska, Piotr Czernia, Magdalena Piotrowska, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility
Mengxin Xu, Zhaoyong Zhang, Yuzhu Sun, et al.
Antiviral Research (2025) Vol. 235, pp. 106082-106082
Closed Access
Unconventionally primed type 1 follicular helper T cells are required for long-lived IgA plasma cell development following mucosal viral infection
Kei Haniuda, Natalie M. Edner, Yuko Makita, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection
Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top